MedTrace Logo

Lorcaserin: Real World Experience in an Insurance-Based Weight Management Clinic

NCT03552107 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 157

Last updated 2019-10-31

No results posted yet for this study

Summary

This is a retrospective, descriptive study that involves de-identified data consisting of weight changes, pertinent vital signs and laboratory values influenced by body weight, and healthcare utilization of patients prescribed lorcaserin at The Center for Weight Management at the Scripps Clinic in San Diego, CA.

Conditions

Interventions

DRUG

Lorcaserin

Treatment initiation with Lorcaserin

Sponsors & Collaborators

  • Eisai Inc.

    collaborator INDUSTRY

  • Scripps Whittier Diabetes Institute

    lead OTHER

Principal Investigators

  • Ken Fujioka, MD · Scripps Clinic Medical Group

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-04-11
Primary Completion
2018-10-11
Completion
2019-04-11
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03552107 on ClinicalTrials.gov